首页> 外国专利> Pharmaceutically acceptable Salt of a Derivative of propanamide; Process for preparing the pharmaceutical composition comprising such a Sa Sa use of this Salt to treat difficulty re syndromeSpiratoria acute pulmonary emphysema, bronchitis, B

Pharmaceutically acceptable Salt of a Derivative of propanamide; Process for preparing the pharmaceutical composition comprising such a Sa Sa use of this Salt to treat difficulty re syndromeSpiratoria acute pulmonary emphysema, bronchitis, B

机译:丙酰胺衍生物的可药用盐;制备包含这种盐的药物组合物的方法;盐;使用这种盐治疗困难综合症螺旋体急性肺气肿,支气管炎,B

摘要

A pharmaceutically acceptable salt of N-[2-(Diethylamino)ethyl]-N-(2-{[2-(4-hydroxy-2-oxo-2,3-dihydro-1,3-benzothiazol-7-yl)ethyl]amino}ethyl)-3-[2-(1-naphthyl)ethoxy]propanamide provided it is not the dihydrobromide or dihydrochloride sa and the use of such a compound as a medicament (for example in the treatment of respiratory diseases (such as asthma or COPD).
机译:N- [2-(二乙氨基)乙基] -N-(2-{[2-(4-羟基-2-氧代-2,3-二氢-1,3-苯并噻唑-7-基)乙基]氨基}乙基)-3- [2-(1-萘基)乙氧基]丙酰胺,只要它不是二氢溴化物或二盐酸盐即可;以及此类化​​合物作为药物的用途(例如在治疗呼吸系统疾病(例如哮喘或COPD)中)。

著录项

  • 公开/公告号CL2008000399A1

    专利类型

  • 公开/公告日2008-10-24

    原文格式PDF

  • 申请/专利权人 ASTRAZENECA AB;

    申请/专利号CL20080000399

  • 发明设计人 WHITTOCK ROBERT;WITHNALL JANE.;

    申请日2008-02-07

  • 分类号A61K31/428;A61P11/06;A61P11/08;C07D277/68;

  • 国家 CL

  • 入库时间 2022-08-21 20:08:31

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号